4//SEC Filing
Erlander Mark 4
Accession 0001628280-21-005335
CIK 0001213037other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 12:24 PM ET
Size
4.7 KB
Accession
0001628280-21-005335
Insider Transaction Report
Form 4
Erlander Mark
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2021-03-23$10.34/sh+965$9,980→ 14,481 total
Documents
Issuer
Cardiff Oncology, Inc.
CIK 0001213037
Entity typeother
Related Parties
1- filerCIK 0001651537
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 12:24 PM ET
- Size
- 4.7 KB